Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 10 studies | 27% ± 11% | |
adventitial cell | 4 studies | 42% ± 4% | |
oligodendrocyte | 4 studies | 19% ± 2% | |
connective tissue cell | 3 studies | 25% ± 6% |
Insufficient scRNA-seq data for expression of PI16 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 72% | 3292.96 | 176 / 245 | 60% | 15.66 | 300 / 502 |
brain | 39% | 570.53 | 1019 / 2642 | 90% | 48.44 | 638 / 705 |
thymus | 82% | 2521.84 | 536 / 653 | 45% | 8.04 | 270 / 605 |
breast | 72% | 2727.33 | 331 / 459 | 49% | 14.11 | 545 / 1118 |
bladder | 95% | 7390.00 | 20 / 21 | 15% | 4.42 | 78 / 504 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.59 | 1 / 1 |
esophagus | 71% | 3911.31 | 1030 / 1445 | 18% | 4.32 | 33 / 183 |
skin | 58% | 2862.35 | 1053 / 1809 | 28% | 8.96 | 132 / 472 |
heart | 85% | 5672.30 | 731 / 861 | 0% | 0 | 0 / 0 |
adipose | 74% | 3170.07 | 894 / 1204 | 0% | 0 | 0 / 0 |
stomach | 48% | 1819.94 | 173 / 359 | 23% | 5.53 | 67 / 286 |
blood vessel | 66% | 2156.18 | 883 / 1335 | 0% | 0 | 0 / 0 |
lung | 49% | 1047.05 | 286 / 578 | 15% | 2.07 | 176 / 1155 |
intestine | 40% | 887.99 | 388 / 966 | 15% | 3.11 | 79 / 527 |
uterus | 40% | 1766.28 | 68 / 170 | 12% | 3.66 | 56 / 459 |
pancreas | 1% | 6.93 | 3 / 328 | 47% | 12.71 | 84 / 178 |
lymph node | 0% | 0 | 0 / 0 | 34% | 5.43 | 10 / 29 |
tonsil | 0% | 0 | 0 / 0 | 29% | 3.39 | 13 / 45 |
muscle | 28% | 326.21 | 225 / 803 | 0% | 0 | 0 / 0 |
ovary | 12% | 258.92 | 21 / 180 | 4% | 1.38 | 19 / 430 |
eye | 0% | 0 | 0 / 0 | 11% | 6.36 | 9 / 80 |
kidney | 1% | 12.71 | 1 / 89 | 9% | 1.11 | 84 / 901 |
adrenal gland | 2% | 23.12 | 6 / 258 | 8% | 0.78 | 18 / 230 |
liver | 0% | 0 | 0 / 226 | 2% | 0.18 | 9 / 406 |
peripheral blood | 1% | 11.21 | 12 / 929 | 0% | 0 | 0 / 0 |
spleen | 0% | 2.79 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0061052 | Biological process | negative regulation of cell growth involved in cardiac muscle cell development |
GO_0005615 | Cellular component | extracellular space |
GO_0030414 | Molecular function | peptidase inhibitor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PI16 |
Protein name | Peptidase inhibitor 16 (PI-16) (Cysteine-rich secretory protein 9) (CRISP-9) (PSP94-binding protein) (CD antigen CD364) |
Synonyms | CRISP9 UNQ289/PRO328 PSEC0164 PSPBP |
Description | FUNCTION: May inhibit cardiomyocyte growth. . |
Accessions | ENST00000373674.4 [Q6UXB8-1] ENST00000647861.1 [Q6UXB8-1] Q6UXB8 ENST00000611814.4 [Q6UXB8-1] |